Skip to main content

Validation of the Persian version of Skindex-16 among older patients with skin diseases

Abstract

Background

Skin conditions often considerably impact the older patients’ psycho-social health and quality of life (QoL). The present study was aimed to examine the validity and reliability of the Persian version of Skindex-16 among older people with skin diseases.

Methods

In this validation study, 260 older patients suffering from a range of skin conditions were recruited from a dermatology clinic in Rasht, Iran. Data were collected using a checklist for demographic and clinical characteristics and the Skindex-16 questionnaire. In this study, validity (face, content, and construct) and reliability (Cronbach’s alpha) of the Skindex-16 were assessed and reported.

Results

The mean age of participants was 64.51 ± 5.04 years. The results of confirmatory factor analysis showed that the model had acceptable fitness into the expected three-factor structure [χ 2 /df = 249.363, P < 0.001; GFI = 0.961; TLI =0.952; RMSEA = 0.078 (90% CI = 0.06, 0.09) and SRMR = 0.06]. The reliability analysis results confirmed that the values of Cronbach’s alpha coefficient for Skindex-16 were in the acceptable range (0.923).

Conclusions

Our evaluation of the Skindex-16 indicates that it is reliable and a valid instrument that can be used for measuring QoL for Iranian dermatologic patients.

Peer Review reports

Introduction

Aging is associated with a decline in physiological functions, functional capacity, and the onset of many diseases [1]. Like other biological systems, the skin, which provides a large body interface with the environment, grows, matures, and ages throughout life [2]. With advancing age, the prevalence of some skin disorders increases [3]. Skin aging is accompanied by a decrease in the functional capacity that increases the vulnerability to cutaneous problems and the subsequent development of dermatoses such as xerosis, pruritus, and eczema, and skin cancers [4]. The most common skin disorders in older adults consisted of dermatitis, fungal infections, pruritus, benign and malignant tumors [2]. In a review study of 4099 elderly patients, five common skin diseases were eczema dermatitis (20.4%), fungal infections (15.8%), pruritus (11.5%), and bacterial (7.3%) and viral (6.7%) infections, respectively [5]. In Iran, Morowatisharifabad et al. [6] reported that the most frequent skin problem among older people was dry skin (30.25%) followed by skin pruritus (9.5%), and flaking of the skin (8.25%). Malekzad et al. (2007) [7] also found that 267 out of 456 institutionalized older adults in Iran (58.6%) suffered from at least one type of skin disease. Dry skin, seborrheic keratosis, and pressure ulcers were the most common skin disorders among them [8].

Studies of quality of life (QoL) of patients with skin diseases becoming more important [9]. Chronic inflammatory skin diseases affect the physical, social, and psychological aspects of a person’s life [10, 11]. Severe skin diseases and the presence of symptoms such as itching and pain can result in significant psychosocial consequences [12]. Comorbid psychiatric conditions, including depression, anxiety, and social panic, are often associated with the itch and scratch cycle [13]. Embarrassment due to deformity of the skin can deteriorate the self-esteem and self-confidence of patients and may lead to social isolation [14]. The impact of skin conditions on social relationships might be far more problematic than its related physical limitations [15]. So, it is suggested to consider improving all aspects of the health of these patients. Health-related QoL (HrQoL) is an indicator that can reflect these aspects [16]. Furthermore, the HrQoL assessment provides homogeneous information for the impacts of different skin diseases, as well as the outcomes of different treatments [17].

Culture is an important factor that impacts the perception of QoL among patients with skin diseases. In Iran, cultural aspects such as Islamic clothing can actually ease or exacerbate the symptoms of skin diseases. Wearing particular types of clothes can aggravate skin irritation and trigger flare-ups associated with psoriasis. On the contrary, clothing prevents direct exposure to sunlight and masks symptoms such as red and dry skin, and can improve social aspects [18]. Furthermore, cultural beliefs may increase the distress of patients with skin diseases. For example, Iranian married women with developing vitiligo after marriage may have marital problems that might lead to divorce [19].

Given the impact of skin diseases have on the QoL of older people [20], an accurate, sensitive instrument is required to measure the HrQoL of this group of patients. To address this need, several instruments have been developed to measure the HrQoL of patients with skin problems include Skindex-29 [21], Douleur Neuropathique 4 (DN4), 12-item General Health Questionnaire (GHQ-12) [22], Skindex-16 [23], and Dermatology Life Quality Index (DLQI). DN4 is one of the questionnaires that can be useful in the assessment of neuropathic pain. This questionnaire with 10 items is very specific and only assesses the quality of pain [24]. GHQ-12 is a screening tool to detect mental disorders in the general population and it has not been used specifically for a group of patients [22]. DLQI is the only disease-specific quality of life instrument that was validated among Iranian patients with vitiligo and psoriasis [25, 26].

The Skindex-16 is a commonly used tool that was designed by Chren et al. [23] to measure the effect of skin diseases on the QoL of patients. An original 62-item questionnaire [21] was modified to 29-items [27], and finally to 16 items [23]. It is a self-administered questionnaire that was originally created in English and measures the impacts of skin disease on a patient’s QoL. The Skindex-16 has advantages over the Skindex-29, in that it is a brief, single-page version with fewer items [28]. Adaptations of Skindex-16 have already been made into several languages, including English [23], Italian [29], Arabic [30], Chinese [31], Japanese [32], Moroccan Arabic [33], and Brazilian [34]. In Iran, Soghi et al. [35] translated the scale into Persian based on World Health Organization protocol and assessed content validity, inter-item consistency, and test-retest reliability among a group of Iranian patients with Neurofibromatosis Type 1. However, due to the significant role of culture and context in perceiving pain, physical and psychological symptoms [36], and QoL [37], it is necessary to validate Skindex-16 in Iran. Therefore, this study aimed to determine the psychometric properties (face, content, construct validity, and internal reliability) of the Persian version of the Skindex-16 that was previously translated by Soghi et al. [35] in a sample of older patients with skin diseases.

Methods

The study sample consisted of 260 older patients with skin disease recruited via convenience sampling method from a dermatology clinic of Razi hospital, Rasht, Iran. Inclusion criteria were age 60 years old or over and a diagnosis of dermatological disease. Participants who were unable to communicate verbally were excluded from the study.

The minimum sample size required for conducting factor analysis is equal to five to ten subjects per item [38]. Furthermore, the general rule suggested by Boomsma and Hoogland [39] for factor analysis is using samples greater than 200.

Given the expected response rate from 70 to 80% due to conditions such as culture, education, and response quality, We recruited a total of 325 older patients in the study. However, as expected, 20% of responses did not meet the quality assessment, thus, a sample size of 260 was utilized to report the findings from the study.

The data collection was lasted 2 months, from 20th of April to 20th of Jun 2020. A trained reviewer (first author) gathered the data by face-to-face interview.

Instruments

Data were collected using a demographic and clinical characteristics checklist and the Skindex-16 questionnaire.

A demographic and clinical characteristics checklist was used to collect information about the older patients’ age, gender, marital status, education level, job, living arrangement, history of psychological or physical problems, type of skin disease, duration of skin disease, and duration under treatment.

The Skindex-16 was developed by Chren et al. [23] to measure the impact of skin diseases on HrQoL, has been translated and validated in several languages and it is the most commonly used instrument to measure HrQoL in patients with skin diseases. The Skindex-16 consists of 16 items which are scored on a seven-point Likert scale, from 0 (never bothered) to 6 (always bothered). The range of possible scores was from 0 to 96, where lower scores indicate higher levels of QoL. In this study, we used the Persian version of the Skindex-16, which was translated based on the World Health Organization protocol in a previous study [35].

Access to the questionnaire, or permission to use the Skindex-16, can be found on https://eprovide.mapi-trust.org/instruments/skindex.

Face validity assessment

For the face validity, ten older patients were asked about the appropriateness of the items of the instrument to measure the targeted construct. They were also asked about the level of difficulty, the degree of inconsistency, ambiguity of expressions [40]. The items of the scale were corrected according to their comments.

Content validity assessment

The content validity of the Persian version of the Skindex-16 was evaluated by qualitative and quantitative methods. For the qualitative content validity, the expert panel was defined as individuals who were experts in dermatology, gerontology, psychology, and educational nursing. They were asked to give feedback on the items of the Skindex-16 scale in terms of relevancy, understandability/clarity wording, item allocation, grammar, and scaling [41]. A final version of the scale was created after applying their comments.

The Content Validity Ratio (CVR) and the Content Validity Index (CVI) were calculated for the quantitative content validity analysis. In this way, 15 experts were asked to rate the essentiality of the Skindex-16 items on a 3-point Likert-type scale consisting of “not essential”, “useful but not essential”, and “essential” [40, 42]. Then the questionnaire’s CVR was assessed; according to the Lawsche table, if the item score was over 0.49, the item was considered as an appropriate and necessary one [43]. For the Item-CVI (I-CVI), the value of 0.79 or greater shows the item to be appropriate [44] The CVR and I-CVI for the items of Skindex-16 are presented in Table 1.

Table 1 The I-CVI and CVR for the Skindex-16 Scale items

Construct validity assessment

Factor structure validity

The results of the previous studies [23, 29,30,31,32,33,34] have shown a three-factor structure – symptoms (items 1 to 4), emotions (items 5 to 11), and functioning (items 12 to 16) – for Skindex-16. So, in this study, a confirmatory factor analysis (CFA) was carried out to confirm the three-factor structure of Skindex-16 for a sample of older patients with skin diseases. Various indexes to evaluate fit were used: Chi-Square/degrees of freedom (χ2/df); an adjusted model showing a value between 2 and 3; goodness of fit index (GFI), values near to 0.90 are recommended; Tucker-Lewis index (TLI), values higher than 0.90 and 0.95 are considered as an indicator of satisfactory and good fit, respectively; standardized root mean square residual (SRMR), values less than 0.05 are considered satisfactory, however values close to 0.08 may also be acceptable; and root mean square error of approximation (RMSEA), values < 0.05 as excellent and < 0.08 as acceptable [45,46,47].

Reliability assessment

For reliability analysis, Cronbach’s alpha was determined to assess internal reliability. A coefficient of Cronbach’s alpha greater than 0.70 indicates that the scale is highly reliable [48].

Ethical consideration

The study was approved by the Ethics Committee of Qazvin University of Medical Sciences, Qazvin, Iran (IR.QUMS.REC.1398.269). Older patients were informed about the objectives and procedures of the study. Furthermore, they were instructed that participation was voluntary and that it would not affect their medical care. The confidentiality of the patients’ information was guaranteed. Informed consent was signed by all the older patients before completing the questionnaires.

Statistics

The Statistical Package for Social Sciences version 21.0 software for Windows (IBM SPSS Statistics for 265 Windows, Version 21.0. Armonk, NY: IBM Corp., USA) and Mplus (Version 7.3, October 2014) software with maximum likelihood estimation were used for statistical calculations. Descriptive statistics of the variables are presented as mean ± standard deviation and n (%). Descriptive analysis to present population norms and reliability analysis, using Cronbach alpha coefficients, was conducted using the entire sample. The normal distributions of the data were confirmed by skewness and kurtosis. CFA was used for evaluating the construct validity of the Skindex-16.

Results

A total of 260 patients were enrolled. The mean age (SD) of participants was 64.51 (5.04) years. More than half of the older patients were female (n = 148, 56.9%) and illiterate (n = 64, 24.6%) or in the elementary educational level (n = 72, 27.7%). Demographic characteristics of the sample were summarized in Table 2.

Table 2 Demographic characteristics of the sample

The Cronbach’s alpha coefficients of Skindex-16 and its scales were high (0.859-0.945), which signified very good internal consistency reliability of instruments (Table 3). According to the results, all of the item-total correlation values are greater than 0.30 that are acceptable [49].

Table 3 Descriptive information and Cronbach’s alpha of Skindex-16

CFA was used to test the construct validity of the Skindex-16. The results of the statistical analysis showed that the model was confirmed in the studied samples [χ 2 /df = 249.363, P < 0.001; GFI = 0.961; TLI =0.952; RMSEA = 0.078 (90% CI = 0.06, 0.09) and SRMR = 0.06]. The results indicated to be a goodness of fit indices. The values of two indexes, GFI/TLI and RMSEA were at an acceptable level [50]. The factor loading of all the questions was above 0.6 that is approved [51]. When the fit indexes obtained as a result of CFA were examined, it was determined that the model formed was structurally valid. The structural shape of the model is given in Fig. 1.

Fig. 1
figure 1

The three-factor model for Skindex-16 obtained from confirmatory factor analysis. Note: f1 = Symptoms, f2 = Emotions, f3 = Functioning

Discussion

Skin conditions can significantly influence body image and psychological health and consequently, reduce QoL [52]. This study was conducted to determine the psychometric properties of the Persian version of the Skindex-16 among older participants with dermatological conditions referred to Razi Clinic in Rasht, Iran. In order to evaluate the underlying structure of this questionnaire, the CFA method was used. The results of CFA indicated that the three-factor structure of Skindex-16 was acceptable. Results of the current study are in sync with other international studies confirming the three-dimensionality of the scale [23, 29,30,31,32,33,34]. For example, He et al. (2014) reported the CFA with acceptable fitness into the expected three-factor structure of the Skindex-16 among 225 Chinese patients with skin disease [32]. Furthermore, in a study by Cárcano et al. (2018), an acceptable model fit was obtained for a three-factor structure among 110 Brazilian patients with skin disease [35].

In the present study, one of the factors was the symptoms of skin diseases. Physical impacts of the skin conditions depend on the extent of the rash, how active the rash is, its area, and the related symptoms [53]. Patients with skin disease may experience severe symptoms, such as itching, pain, and discomfort that can have a profound impact on people’s mental health. This most noticeable impact could be due to the visibility of most symptoms, and the influence on daily and work activities [9]. Furthermore, severe skin-related symptoms on the face and body can worsen the self-esteem and self-confidence of dermatologic patients, which significantly affect their social activities involvement [54].

The results CFA showed that the emotional dimension was another acceptable factor of Skindex-16. The burden of skin diseases causes a wide range of unfavorable impacts on the physical, psychological, and social aspects of a patient’s life [52], resulting in impairment in HrQoL. The psychological factor as a general term includes psychological and emotional reactions that occur in a person’s life [55, 56]. Regarding socio-cultural perspective, people judge others based on their physical appearance [57]. Similarly, Rosen and Underwood (2010) found that those who have higher facial attraction are more favourable in comparison with those who have less facial attraction [58]. In the Iranian society, physical attractiveness also plays a crucial role in the social relationships and it is considered as selection criteria for desirability [59]. So, the majority of the Iranian patients with skin diseases suffer from emotional problems due to their chronic nature and its impact on the physical appearance and individuals’ perception of their appearance [35]. Furthermore, there are complex, two-sided associations between psychological factors and dermatological conditions [53]. Psychological stress is related to many common skin diseases and conditions, it seems to be the reason for their onset or aggravation. Psychological impacts related to skin diseases such as fear, mental distress, embarrassment, and depression can affect negatively patients’ QoL [54, 60, 61].

Based on the results CFA, the social performance (functioning) was an acceptable factor of the Skindex-16 scale. Skin-related symptoms not only result in physical discomfort and inconvenience but also influence the personal and social lives of patients [54]. Because the skin is important in human aesthetics and appearance. It is also an important factor in nonverbal communication and interpersonal relations [15]. Many patients limit their physical and social activities, including sports and work, because of reluctance to allow others to see their skin disease [11]. Moreover, severe skin-related symptoms on the face and body can worsen the self-esteem and self-confidence of patients, which significantly affect their involvement in social activities and increase distress [9].

With respect to reliability, the Cronbach’s alpha coefficients for the Skindex-16 and its three dimensions were from 0.859-0.945, which indicated satisfactory internal consistency of the Persian version of the scale. In a study by Chren, Lasek [23] on the original Skindex-16 version, Cronbach’s alpha for the symptoms, emotions, and function were 0.86, 0.93, and 0.92, respectively. In the study of Higaki, Kawamoto [32] the internal reliability of the scale at a high level with Cronbach’s alpha was equal to 0.92. In the study of AlGhamdi and AlShammari [30] which examined the Arabic version of Skindex-16 among the skin patients, the Cronbach’s alpha coefficient for the total instrument was 0.93.

Limitations

There were some limitations in this study. Since the study was performed among the older patients referred to one dermatological clinic, it may be difficult to generalize the results and state that Skindex-16 is valid and reliable for all Iranian patients with skin diseases. The researchers’ attempt to measure the test-retest reliability of the scale failed, as it was evaluated in an inappropriate time interval (2 weeks). Because the patients were recruited from a dermatological clinic and they underwent the treatments that affected the state of their problems and their QoL was likely to change. Another limitation refers to the response bias, including social desirability bias that seems to be relevant to the geriatric population [62].

Conclusions

In general, the findings of the present study indicated that the Persian version of the Skindex-16 has a three-factor structure and acceptable validity and reliability, thus justifying its use as a way of evaluating QoL in Iranian older patients with skin conditions. Its shortness and ease of implementation provide researchers and clinicians with a method of readily and extensively using it for QoL assessment in this group of patients.

Suggestions for future studies

It is suggested that future studies would include patients from multi-center clinics, carry out the same research among patients from different socio-cultural areas and environments, and evaluate the test-retest reliability at an appropriate time interval.

Abbreviations

QoL:

Quality of Life

HrQoL:

Health-Related Quality of Life

DN4:

Douleur Neuropathique 4

GHQ-12:

12-item General Health Questionnaire

DLQI:

Dermatology Life Quality Index

CFA:

Confirmatory factor analysis

References

  1. Barbieri E, Agostini D, Polidori E, Potenza L, Guescini M, Lucertini F, et al. The pleiotropic effect of physical exercise on mitochondrial dynamics in aging skeletal muscle. Oxidative Med Cell Longev. 2015;2015:917085.

    Article  Google Scholar 

  2. Blume-Peytavi U, Kottner J, Sterry W, Hodin MW, Griffiths TW, Watson RE, et al. Age-associated skin conditions and diseases: current perspectives and future options. The Gerontologist. 2016;56(Suppl_2):S230–S42.

    Article  PubMed  Google Scholar 

  3. Hahnel E, Lichterfeld A, Blume-Peytavi U, Kottner J. The epidemiology of skin conditions in the aged: a systematic review. J Tissue Viability. 2017;26(1):20–8.

    Article  PubMed  Google Scholar 

  4. Assar S, Mirzaei T, Ravari A, Vakilian A, Rezahosseini O, Hosseini F, et al. A study of the status of the elderly; bacterial infections, their causes, prevention, and control methods. J Occup Health Epidemiol. 2016;5(3):182–93.

    Article  Google Scholar 

  5. Yalçın B, Tamer E, Toy GG, Öztaş P, Hayran M, Allı N. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672–6.

    Article  PubMed  Google Scholar 

  6. Morowatisharifabad MA, Bayati F, Rahaei Z, Ebrahimzadeh Ardakani M, Namayandeh SM. Attitude to, knowledge and practice of skin care in older adults in Sarakhs city, and prevalence of some skin problems among them. Elder Health J. 2017;3(2):67–73.

    Google Scholar 

  7. Malekzad F, Rahmati M, Taheri A. Prevalence of skin diseases among nursing home patients in elderly home nursings in North of Tehran. Pajoohande. 2007;12(3):253-8.

  8. Derek Richard S, Hamm-Ming S, Fu-Sen H, Yung-Ling L, Suh-Jen C, Yueliang Leon G. Prevalence of skin disease among nursing home patients in southern Taiwan. Int J Dermatol. 2002;41(11):754–9.

  9. Abolfotouh MA, Al-Khowailed MS, Suliman WE, Al-Turaif DA, Al-Bluwi E, Al-Kahtani HS. Quality of life in patients with skin diseases in central Saudi Arabia. Int J Gen Med. 2012;5:633.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Jafferany M, Pastolero P. Psychiatric and psychological impact of chronic skin disease. Prim Care Companion CNS Disord. 2018;20(2):17nr02247.

    Article  PubMed  Google Scholar 

  11. Peters EM. Stressed skin?–a molecular psychosomatic update on stress-causes and effects in dermatologic diseases. J Dtsch Dermatol Ges. 2016;14(3):233–52.

    PubMed  Google Scholar 

  12. Verhoeven E, Kraaimaat F, Van De Kerkhof P, Van Weel C, Duller P, Van Der Valk P, et al. Psychosocial well-being of patients with skin diseases in general practice. J Eur Acad Dermatol Venereol. 2007;21(5):662–8.

    PubMed  CAS  Google Scholar 

  13. Jafferany M, Davari ME. Itch and psyche: psychiatric aspects of pruritus. Int J Dermatol. 2019;58(1):3–23.

    Article  PubMed  Google Scholar 

  14. Kim S, Lee J-Y, Oh J-Y, Chekal L, Lee DC. The association between atopic dermatitis and depressive symptoms in Korean adults: the fifth Korea National Health and Nutrition Examination Survey, 2007-2012. Korean J Fam Med. 2015;36(6):261.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Deshpande H, Shivakumar, Kavita M, Tripathy T, Chaturvedi A. Assessment of quality of life in patients with skin disorders undergoing ayurvedic Panchakarma (biopurification) as management. J Evid Based Complementary Altern Med. 2016;21(3):215–20.

    Article  PubMed  Google Scholar 

  16. Megari K. Quality of life in chronic disease patients. Health Psychol Res. 2013;1(3):e27.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Nguyen SH, Nguyen LH, Vu GT, Nguyen CT, Le THT, Tran BX, et al. Health-related quality of life impairment among patients with different skin diseases in Vietnam: a cross-sectional study. Int J Environ Res Public Health. 2019;16(3):305.

    Article  PubMed Central  Google Scholar 

  18. Jobanputra R, Bachmann M. The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa. Int J Dermatol. 2000;39(11):826–31.

    Article  PubMed  CAS  Google Scholar 

  19. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1(1):1–3.

    Article  Google Scholar 

  20. Farage MA, Miller KW, Sherman SN, Tsevat J. Assessing quality of life in older adult patients with skin disorders. Global J Health Sci. 2012;4(2):119.

    Article  Google Scholar 

  21. Chren M-M, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Investig Dermatol. 1996;107(5):707–13.

    Article  PubMed  CAS  Google Scholar 

  22. Najarkolaei FR, Raiisi F, Rahnama P, Fesharaki MG, Zamani O, Jafari MR, et al. Factor structure of the Iranian version of 12-item general health questionnaire. Iran Red Crescent Med J. 2014;16(9):e11794.

    Google Scholar 

  23. Chren M-M, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg. 2001;5(2):105–10.

    Article  PubMed  CAS  Google Scholar 

  24. Celik S, Yenidunya G, Temel E, Purisa S, Uzum AK, Gul N, et al. Utility of DN4 questionnaire in assessment of neuropathic pain and its clinical correlations in Turkish patients with diabetes mellitus. Prim Care Diabetes. 2016;10(4):259–64.

    Article  PubMed  CAS  Google Scholar 

  25. Aghaei S, Moradi A, Ardekani GS. Impact of psoriasis on quality of life in Iran. Indian J Dermatol Venereol Leprol. 2009;75(2):220.

    Article  PubMed  Google Scholar 

  26. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4(1):1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Chren M-M, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.

    Article  PubMed  CAS  Google Scholar 

  28. Chren M-M. The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin. 2012;30(2):231–6.

    Article  PubMed  CAS  Google Scholar 

  29. Picardi A, Pasquini P, Abeni D, Fassone G, Mazzotti E, Fava GA. Psychosomatic assessment of skin diseases in clinical practice. Psychother Psychosom. 2005;74(5):315–22.

    Article  PubMed  Google Scholar 

  30. AlGhamdi KM, AlShammari SA. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity. Int J Dermatol. 2007;46(3):247–52.

    Article  PubMed  Google Scholar 

  31. He Z, Lu C, Chren M-M, Zhang Z, Li Y, Ni X, et al. Development and psychometric validation of the Chinese version of Skindex-29 and Skindex-16. Health Qual Life Outcomes. 2014;12(1):190.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Higaki Y, Kawamoto K, Kamo T, Horikawa N, Kawashima M, Chren MM. The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Dermatol. 2002;29(11):693–8.

    Article  PubMed  Google Scholar 

  33. El Fakir S, Baybay H, Bendahhou K, Obtel M, Benchat L, Mernissi FZ, et al. Validation of the Skindex-16 questionnaire in patients with skin diseases in Morocco. J Dermatol Treat. 2014;25(2):106–9.

    Article  Google Scholar 

  34. Cárcano CBM, de Oliveira CZ, Paiva BSR, Paiva CE. The Brazilian version of Skindex-16 is a valid and reliable instrument to assess the health-related quality of life of patients with skin diseases. PLoS One. 2018;13(3):e0194492.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Soghi I, Saeedi S, Sanagoo A, Jouybari L, Ebrahimirad M, Mehravar F. Quality of life in a group of Iranian patients with neurofibromatosis type 1 with cutaneous expressions. J Maz Univ Med Sci. 2018;28(162):95–103.

    Google Scholar 

  36. Miller ET, Abu-Alhaija DM. Cultural influences on pain perception and management. Pain Manag Nurs. 2019;20(3):183–4.

    Article  PubMed  Google Scholar 

  37. Galloway S. Cultural participation and individual quality of life: a review of research findings. Appl Res Qual Life. 2006;1(3-4):323–42.

    Article  Google Scholar 

  38. Munro BH. Statistical methods for health care research. Philadelphia: Lippincott Williams & Wilkins; 2005.

  39. Boomsma A, Hoogland JJ. The robustness of LISREL modeling revisited. In: Structural equation models: Present and future. A Festschrift in honor of Karl Jöreskog, vol. 2(3); 2001. p. 139–68.

    Google Scholar 

  40. Molaei M, Etemad K, Taheri Tanjani P. Prevalence of elder abuse in Iran: a systematic review and meta analysis. Iran J Ageing. 2017;12(2):242–53.

    Google Scholar 

  41. Colton D, Covert R. Designing and constructing instruments for social research and evaluation. San Francisco: Wiley; 2007.

  42. DeVon HA, Block ME, Moyle-Wright P, Ernst DM, Hayden SJ, Lazzara DJ, et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh. 2007;39(2):155–64.

    Article  Google Scholar 

  43. Lawshe C. A qualitative approach to content validity. Pers Psychol. 1975;25:563–75.

    Article  Google Scholar 

  44. Yaghmaie F. Content validity and its estimation. J Med Educ. 2003;3(1):25-27.

  45. da Fonseca PN, da Silva Nascimento B, Macêdo Barbosa LHG, Vione KC, Veloso Gouveia V. Flourishing scale: evidence of its suitability to the Brazilian context; 2015.

    Google Scholar 

  46. Amini-Tehrani M, Nasiri M, Jalali T, Sadeghi R, Ghotbi A, Zamanian H. Validation and psychometric properties of suicide behaviors questionnaire-revised (SBQ-R) in Iran. Asian J Psychiatr. 2020;47:101856.

    Article  PubMed  Google Scholar 

  47. Amini-Tehrani M, Sadeghi R, Nasiri M, Jalali T, Zamanian H. Suicide-related interpersonal needs of young Iranian people: a preliminary validation of thwarted belongingness and perceived burdensomeness constructs. Clin Psychol Psychother. 2020;28(2):422-37.

  48. Alpar R. Reliability, applied multivariate statistical techniques. 3rd ed. Ankara: Detay Publishing; 2011.

    Google Scholar 

  49. Cristobal E, Flavian C, Guinaliu M. Perceived e-service quality (PeSQ). Manag Serv Qual. 2007;17(3):317-40.

  50. Bialosiewicz S, Murphy K, Berry T. An introduction to measurement invariance testing: resource packet for participants. Washington: American Evaluation Association; 2013. p. 1–37.

  51. Tabachnick BG, Fidell LS, Ullman JB. Using multivariate statistics. Boston: Pearson; 2007.

    Google Scholar 

  52. Zhang X-j, Wang A-p, Shi T-y, Zhang J, Xu H, Wang D-q, et al. The psychosocial adaptation of patients with skin disease: a scoping review. BMC Public Health. 2019;19(1):1404.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Paerna E, Aluoja A, Kingo K. Quality of life and emotional state in chronic skin disease. Acta Derm Venereol. 2015;95(3):312–6.

    Article  Google Scholar 

  54. He Z, Marrone G, Ou A, Liu H, Ma L, Huang Y, et al. Factors affecting health-related quality of life in patients with skin disease: cross-sectional results from 8,789 patients with 16 skin diseases. Health Qual Life Outcomes. 2020;18(1):1–9.

    Article  Google Scholar 

  55. Van Leeuwen C, Kraaijeveld S, Lindeman E, Post M. Associations between psychological factors and quality of life ratings in persons with spinal cord injury: a systematic review. Spinal Cord. 2012;50(3):174–87.

    Article  PubMed  Google Scholar 

  56. Van Mierlo ML, Schröder C, van Heugten CM, Post MW, de Kort PL, Visser-Meily JM. The influence of psychological factors on H ealth-R elated Q uality of L ife after stroke: a systematic review. Int J Stroke. 2014;9(3):341–8.

    Article  PubMed  Google Scholar 

  57. Cash TF, Pruzinsky T. Body image: A handbook of theory, research, and clinical practice. In: Future challenges for body image theory, research, and clinical practice; 2002. p. 509–16.

    Google Scholar 

  58. Rosen LH, Underwood MK. Facial attractiveness as a moderator of the association between social and physical aggression and popularity in adolescents. J Sch Psychol. 2010;48:313–33.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Mozaffari Niya N, Kazemi M, Abazari F, Ahmadi F. Iranians’ perspective to cosmetic surgery: a thematic content analysis for the reasons. World J Plast Surg. 2019;8(1):69–77.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Dixon L, Witcraft S, McCowan N, Brodell R. Stress and skin disease quality of life: the moderating role of anxiety sensitivity social concerns. Br J Dermatol. 2018;178(4):951–7.

    Article  PubMed  CAS  Google Scholar 

  61. Hong J, Koo B, Koo J. The psychosocial and occupational impact of chronic skin disease. Dermatol Ther. 2008;21(1):54–9.

    Article  PubMed  Google Scholar 

  62. Soubelet A, Salthouse TA. Influence of social desirability on age differences in self-reports of mood and personality. J Pers. 2011;79(4):741–62.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Our special thanks go to the older patients who helped to make this research possible. We would like to thank the Research Council of Qazvin University of Medical Sciences for supporting this research financially.

Funding

This research was funded by Research Council of Qazvin University of Medical Sciences (Grant ID: 14004127).

Author information

Authors and Affiliations

Authors

Contributions

T.MN, SA.M, and F.M. conceived and designed the research method and helped to draft the manuscript. T.MN. collected the data. O.G. performed the statistical analysis. T.MN, SA.M, F.M, and Z.H. revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Seyedeh Ameneh Motalebi.

Ethics declarations

Ethics approval and consent to participate

All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was signed by all the older patients before completing the questionnaires. The study was approved by the Ethics Committee of Qazvin University of Medical Sciences, Qazvin, Iran (IR.QUMS.REC.1398.269).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahdavi nejad, T., Mohammadi, F., Gorgulu, O. et al. Validation of the Persian version of Skindex-16 among older patients with skin diseases. BMC Geriatr 21, 724 (2021). https://doi.org/10.1186/s12877-021-02635-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-021-02635-7

Keywords